[The incidence differences among sex, geographical areas and mean age of diagnosis for liver cancer in China, 1989-2008]
- PMID: 24985372
[The incidence differences among sex, geographical areas and mean age of diagnosis for liver cancer in China, 1989-2008]
Abstract
Objective: Using the incidence data from 1989 to 2008 of liver cancer from population in cancer registration areas in China, the differences and changes of gender, urban and rural areas for liver cancer incidence in different years were studied, and the mean age of incidence was analyzed.
Methods: The incidence data of liver cancer from National Cancer Registration database were sorted and checked. A total of 181 097 new liver cancer cases were collected, covering 711 843 051 person years from 1989 to 2008.Using Poisson regression model, Stratified by gender and areas, changes of incidence gender ratio, ratio of urban and rural, and mean age were analyzed.
Results: After adjusting the age, the liver cancer incidence in male was about 3 times higher than that in females (ranging from 2.64-3.54), and the ratio change between male and female for the 20 years did not have statistically significant (P = 0.150). The incidence ratio between urban and rural areas has increased from 0.51 in 1989 to 0.61 in 2008 (P < 0.01). The mean ages of diagnosis for male and female increased from 57.14 years to 60.34 years, 61.69 years to 66.47 years, respectively from 1989 to 2008. The mean age of liver cancer diagnosis has increased in the 20 years (P < 0.01).
Conclusion: The liver cancer incidence between male and female did not change significantly among 20 years. The difference of liver cancer incidence between urban and rural areas has reduced, and the mean age of diagnosis was deferred.
Similar articles
-
[Incidence and mortality of liver cancer in China: an analysis on data from the National Registration System between 2003 and 2007].Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Jun;33(6):547-53. Zhonghua Liu Xing Bing Xue Za Zhi. 2012. PMID: 22883257 Chinese.
-
[Trend analysis and prediction of cancer incidence in China].Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):581-6. Zhonghua Yu Fang Yi Xue Za Zhi. 2012. PMID: 22943910 Chinese.
-
[Analysis and prediction of liver cancer incidence in China].Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):587-92. Zhonghua Yu Fang Yi Xue Za Zhi. 2012. PMID: 22943911 Chinese.
-
[Analysis and prediction of esophageal cancer incidence trend in China].Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):593-7. Zhonghua Yu Fang Yi Xue Za Zhi. 2012. PMID: 22943912 Chinese.
-
Liver cancer epidemic in China: past, present and future.Semin Cancer Biol. 2011 Feb;21(1):59-69. doi: 10.1016/j.semcancer.2010.11.002. Epub 2010 Dec 7. Semin Cancer Biol. 2011. PMID: 21144900 Review.
Cited by
-
Recent trends in the incidence and survival of stage I liver cancer: a surveillance, epidemiology, and end results analysis.Ann Med. 2022 Dec;54(1):2785-2795. doi: 10.1080/07853890.2022.2131328. Ann Med. 2022. PMID: 36370068 Free PMC article.
-
Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models.Oncotarget. 2016 Jul 26;7(30):47431-47443. doi: 10.18632/oncotarget.10164. Oncotarget. 2016. PMID: 27329727 Free PMC article.
-
Prognostic gene biomarker identification in liver cancer by data mining.Am J Transl Res. 2021 May 15;13(5):4603-4613. eCollection 2021. Am J Transl Res. 2021. PMID: 34150040 Free PMC article.
-
Prognostic risk factor analysis and nomogram construction for primary liver cancer in elderly patients based on SEER database.BMJ Open. 2022 Oct 26;12(10):e051946. doi: 10.1136/bmjopen-2021-051946. BMJ Open. 2022. PMID: 36288830 Free PMC article.
-
Disease burden of liver cancer in China from 1997 to 2016: an observational study based on the Global Burden of Diseases.BMJ Open. 2019 Apr 23;9(4):e025613. doi: 10.1136/bmjopen-2018-025613. BMJ Open. 2019. PMID: 31015269 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical